Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H.
Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549
Doi: 10.1016/j.pan.2014.08.006
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Schemmer Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Solid pseudopapillary neoplasms of the pancreas (SPN) are rare tumors. For patients with unresectable liver metastases of SPN, no standard treatment has been defined so far. Here we report a case of a 40-year-old woman with SPN and metastases confirmed to the liver, and disease progression in the liver after primary tumor resection and chemotherapy with gemcitabine and cisplatin. Chemosaturation with percutaneous hepatic perfusions is a minimally invasive, repeatable regional therapy which delivers chemotherapy directly to the liver while limiting systemic toxicity. As an individual treatment approach, the patient was treated with chemosaturation with percutaneous hepatic perfusions of melphalan. The procedure was performed twice within 8 weeks after which the liver metastases showed a marked reduction in size and vascularization (partial response). Grade 3 leukopenia after the second procedure was managed effectively with granulocyte colony-stimulating factor. No other toxicities were observed. Ten months after initiating treatment, the patient had a good performance status and remained stable. For SPN with unresectable liver metastases and progression despite systemic treatment, repeat chemosaturation with high-dose melphalan may also offer an effective regional treatment option. Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Antimetabolites, Antineoplastic - therapeutic use
- Antineoplastic Agents - therapeutic use
- Antineoplastic Agents, Alkylating - therapeutic use
- Carcinoma, Papillary - drug therapy
- Carcinoma, Papillary - pathology
- Carcinoma, Papillary - secondary
- Cisplatin - therapeutic use
- Deoxycytidine - analogs & derivatives
- Deoxycytidine - therapeutic use
- Female -
- Humans -
- Liver Neoplasms - drug therapy
- Liver Neoplasms - pathology
- Liver Neoplasms - secondary
- Melphalan - therapeutic use
- Pancreatic Neoplasms - pathology
- Treatment Outcome -
- Find related publications in this database (Keywords)
- Hepatic perfusions
- Melphalan
- Metastases
- Pancreas
- Pseudopapillary neoplasms
- Frantz tumor